Pioneering treatment could freeze out phantom limb pain
6 April 2016 | By Victoria White
Cryoablation therapy, a targeted treatment using cold blasts, shows promise in improving the quality of life for patients suffering phantom limb pain...
List view / Grid view
News
Positive study results for Oasmia’s XR17 nanotechnology
6 April 2016 | By Victoria White
The confirmation of XR17 as a drug delivery system creates the potential for licensing opportunities in additional therapeutics outside of oncology...
FDA approves Inflectra (biosimilar infliximab) in the US
6 April 2016 | By Victoria White, Digital Content Producer
With this approval, Celltrion's Inflectra becomes the first biosimilar monoclonal antibody (mAb) medication to receive approval in the US...
CHMP issues positive opinion of AstraZeneca’s pandemic influenza vaccine
5 April 2016 | By Victoria White
This recommendation allows a vaccine containing a strain of pandemic potential to be developed and authorised in advance of a pandemic being declared...
CHMP adopts positive opinion of Trevicta for maintenance treatment of schizophrenia
5 April 2016 | By Victoria White
If approved, this 3‑monthly injection will allow patients to maintain an optimal level of treatment in their blood with fewer administrations...
Encouraging top-line interim results for RHB-104 in RRMS
5 April 2016 | By Victoria White
RedHill has announced encouraging top-line interim results from its CEASE-MS study of RHB-104 in patients with relapsing-remitting multiple sclerosis...
World’s first public dengue immunisation programme starts
5 April 2016 | By Victoria White
Dengvaxia vaccinations of one million students from 6,000 public schools in the Philippines are to begin this year...
Saxenda demonstrates significant improvements in cardiometabolic risk factors
5 April 2016 | By Victoria White
In a three year trial, individuals treated with Saxenda lost more weight (6.1%) than those treated with placebo (1.9%)...
CHMP adopts positive opinion for eribulin in advanced liposarcoma
5 April 2016 | By Victoria White
The European Medicines Agency’s CHMP has adopted a positive opinion for a licence extension for Eisai’s Halaven (eribulin)...
Future proofing – Part 2. PAT – Real time release testing of tablets
4 April 2016 | By Charles Ischi AG | Kraemer Elektronik
What requirements need to be met by a tablet testing system to guarantee a successful product release?
New data for semaglutide and liraglutide presented at ENDO 2016
2 April 2016 | By Victoria White
Semaglutide significantly improved glycaemic control compared to placebo in adults with type 2 diabetes previously managed with diet and exercise alone...
Paul Whittles takes the reins at Sirius Analytical!
1 April 2016 | By Sirius Analytical
Sirius Analytical are pleased to announce that Paul Whittles has been appointed as its new Managing Director...
Daratumumab combination improves PFS in multiple myeloma study
1 April 2016 | By Victoria White
Daratumumab combination treatment regimen improved progression-free survival compared with bortezomib and dexamethasone alone...
Positive topline results from two Phase III dupilumab studies
1 April 2016 | By Victoria White
Sanofi and Regeneron have announced positive topline results from two placebo-controlled Phase III studies evaluating investigational dupilumab in adult patients with inadequately controlled moderate-to-severe atopic dermatitis (AD).
GSK adopts groundbreaking IP approach to expand access to its medicines
31 March 2016 | By Victoria White
Sir Andrew Witty has set out a series of steps designed to help bring innovative GSK medicines to more people living in the world’s poorest countries...
